D-0509-2017 Class III Terminated
FDA drug recall D-0509-2017 was initiated by Dr. Reddy's Laboratories, Inc. on Feb 15, 2017 and is designated Class III. Reason for recall: Failed dissolution specifications - low dissolution results at S3 stage. The recall status is terminated (terminated Dec 19, 2018). Affected quantity: 4404 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 8, 2017
- Initiation Date
- Feb 15, 2017
- Termination Date
- Dec 19, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4404 cartons
Product description
Zenatane (isotretinoin) capsules, 10 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-135-81
Reason for recall
Failed dissolution specifications - low dissolution results at S3 stage.
Distribution pattern
U.S. Nationwide
Code information
Lot # KB60197, Exp 2/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0509-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026